Healthcare Investment Access (HIA): Nordic Excellence, Global Opportunity 

Where Nordic healthcare ventures meet global investors. Sharpen your pitch, elevate your presence, and step into the spotlight. 

Since its launch in November 2024, the eight companies in the 2025 HIA class have moved from preparation to execution—delivering regulatory wins, product launches, US clinical engagement, measurable hospital outcomes, and fresh capital. HIA’s mission is simple: compress time to investor readiness and help Nordic Healthcare entrepreneurs step confidently onto the global stage. 

HIA spotlights the best of Nordic healthcare innovation—companies with novel science, practical design, and teams who build steadily and deliver visibly. We provide the stage and the spotlight; founders turn visibility into execution. 

• Connect directly with leading international investors, venture funds, and strategic partners. 

• Gain expert guidance on how to position your company for global capital engagement, with tailored insights into investor expectations outside the Nordic region. 

• 360° Review & Mentoring — Comprehensive, multi-disciplinary evaluations covering clinical, commercial, regulatory, and financing dimensions. These reviews identify blind spots, align strategic priorities, and sharpen investor readiness.  Two hours of mentoring with seasoned industry experts and investors. Build on your review and focus on narrative development, milestone planning, identifying funding sources and market-entry strategies to elevate professionalism and execution and polish your story. 

• Maximize visibility through curated investor interactions and spotlight appearances at premier events: including the DNB Carnegie Nordic Healthcare Conference in Oslo, a strategically curated European Healthcare Investor Forum in Zurich and the Nordic-American Healthcare Conference in NY.